Den af ansøgeren foreslåede anprisning havde følgende ordlyd: »Beta-glucan fra byg har vist sig at reducere kolesterolindholdet i blodet. Risikoen for hjertesygdom kan reduceres, når kolesterolindholdet i blodet sænkes«.
The claim proposed by the applicant was worded as follows: ‘Barley beta-glucan has been shown to reduce blood cholesterol. Blood cholesterol lowering may reduce the risk of heart disease’.